Stay updated on Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.

Latest updates to the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now indicates that no participants are being recruited and adds user-focused guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study. It also updates the Interventions header formatting and the site revision label (from v3.5.5 to v3.6.0).SummaryDifference0.3%

- Check17 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5. This indicates a minor update to the page's content or metadata.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page’s revision tag was updated from v3.5.3 to v3.5.4, signaling a minor version update in the content management system. This appears to be a behind-the-scenes change rather than a modification to user-visible content.SummaryDifference0.0%

- Check46 days agoChange DetectedThe Taiwan location entry Taoyuan District, Taiwan was removed and Taoyuan, Taiwan was added to the study's list of sites, updating the geographic coverage in Taiwan.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page’s displayed application/version revision updates from v3.5.0 to v3.5.3, reflecting a software release without changing the study details.SummaryDifference0.0%

- Check96 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.